Nasdaq News

(RTTNews) - Shares of Iovance Biotherapeutics, Inc. (IOVA) are gaining about 33 percent on Tuesday morning after the company announced its decision to raise its full year 2026 total revenue guidance range to $410 to $420 million, driven by strong U.S. demand for Amtagvi and Prole

Key PointsNuScale won’t deploy its first SMRs until the early 2030s.

Key PointsEthereum’s long-awaited Glamsterdam update will arrive in October.

The S&P 500 Index ($SPX ) (SPY ) closed down by -0.77% on Monday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.08%. December E-mini S&P futures (ESZ26 ) fell -0.76%, and December E-mini...

Corn futures posted losses of 1 to 5 ½ cents across the board on Monday, pulling off some of the early lows at the close. The CmdtyView national average Cash Corn price was down 5 1/4 cents at $4.79 3/4. Following last week’s US/China meeting, China dropped tariffs on several...

Live cattle futures posted modest losses of 57 cents to $1.42 at the Monday close. Cash trade has yet to be reported this week, with Monday mostly compiling showlists, as trade has been light in recent weeks. Feeder cattle futures were down $1.32 to $3.02 on Monday. The CME Feeder...

Key PointsThe Director traded 400 shares at $351.11 per share for a total value of $140,444 on September 17, 2026.

In trading on Tuesday, the WisdomTree Artificial Intelligence and Innovation Fund ETF is outperforming other ETFs, up about 1.9% on the day. Components of that ETF showing particular strength include shares of Bloom Energy, up about 12.3% and shares of Cerebras Systems, up abou

Key PointsYour spousal benefits may equal up to 50% of your spouse's monthly benefit.

Key PointsThe Vanguard Total International Stock ETF (VXUS) lets you invest in the entire international market at once.

(RTTNews) - On Tuesday, Veracyte (VCYT) announced new findings from a retrospective analysis of the Phase 3 NRG/RTOG 0815 trial showing that its Decipher Prostate Genomic Classifier can identify intermediate-risk prostate cancer patients more likely to benefit from adding short-t

(RTTNews) - Eli Lilly (LLY) said a new analysis found that people taking Zepbound 15 mg lost an average of 4.5% more body weight than those taking Wegovy HD at 72 weeks. The comparison was based on data from separate studies rather than a direct head-to-head trial.

Key PointsVertiv Holdings provides the power management and cooling systems that keep AI data centers from overheating.

(RTTNews) - Moleculin Biotech (MBRX) has completed enrolment in Part A of its pivotal Phase 2/3 MIRACLE trial evaluating Annamycin in combination with cytarabine (AnnAraC) in adults with relapsed or refractory acute myeloid leukemia.

Key PointsArtificial intelligence (AI) is a massive part of SpaceX's business, with analysts projecting it could bring in $275 billion in revenue by the end of the decade.

Key PointsViking Therapeutics is a healthcare company that has a promising GLP-1 drug in its portfolio.

Key PointsColgate-Palmolive, Procter & Gamble, and Coca-Cola have durable businesses that can pay you for a lifetime.

Key PointsCME dominates the global derivatives market with exceptional profitability and high net margins.

Key PointsIn a challenging environment, Carnival continues to deliver growth and higher yields.

Key PointsNu stock took a $6.5 billion hit on Monday after unconfirmed reports had it interested in acquiring a European fintech platform.